The Forward P/E of Hybrigenics SA (ALHYG.PA) is N/A.
Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.
| Ticker | Name | Value |
|---|---|---|
| RENE.L | ReNeuron Group PLC | 1820.39 |
| IPH.PA | Innate Pharma SA | 22.78 |
| ADOC.PA | Adocia SA | 0.72 |
| ALNOV.PA | Novacyt SA | 1.75 |